26 April 2017
Dechra Veterinary Products has revealed a new product for the treatment and metaphylaxis of the most common outbreak of disease among broiler chickens.
Phenocillin®, a 800 mg/g powder for use in drinking water, has been devised for the treatment of necrotic enteritis caused by Clostridium perfringens. Its active ingredient is Phenoxymethylpenicillin.
Necrotic Enteritis can be treated with a variety of therapeutic antibiotics but first choice antibiotics¹ for treatment are narrow spectrum antibiotics, like Phenoxymethylpenicillin.
It is lactose free with high solubility making it ideal for concentrated stock solutions and convenient for modern poultry farming. There is a zero withdrawal time so egg production is unaffected.
Phenocillin is the latest addition to its SoluStab range which also includes Soludox®, Soludox® (turkey), Octacillin® (pig), Solamocta®, Solacyl®, and Metaxol® and is available in the UK and Republic of Ireland.
Dechra Brand Manager Emma Jennings said: “Necrotic Enteritis is the most common bacterial disease in modern broiler flocks that can be financially devastating for farmers.
“The high concentration means easy dosage and handling with less waste and the lactose free formula reduces the risk of biofilm development resulting in a high quality and effective product, supporting the responsible use of antimicrobials.
“Phenocillin is a highly effective treatment and we anticipate it will become the preferred solution for veterinary professionals and end users to treat this disease that can very suddenly devastate broiler flocks.”
Bacterial disease in chickens target for new Dechra treatment